CVS will begin selling CBD topical products in its stores, but notably leaves out dietary supplement and functional foods.
Photo © iStockphoto.com/AlenaPaulus
Curaleaf Holdings, Inc. (Wakefield, MA) announced during an earnings call that it has developed an agreement with CVS Health Corp. to begin selling its CBD products in CVS stores. The products, which include creams, sprays, and lotions infused with CBD, will be sold in 800 stores across eight states, including California, Illinois, Colorado, and Alabama. Notably, however, the pharmacy chain will not be selling any CBD products marketed as dietary supplements or foods fortified with CBD. In addition to a lineup of CBD-based lotions, tinctures, and vape pens as part of its Curaleaf Hemp line, the company also manufactures medical-grade cannabis products for the legal marijuana markets, operating 40 marijuana dispensaries across 12 states.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.